KRYS Award Disclosure
Sutherland Everett Rand · SEC Form 4 · Filed Sep 16, 2026
Award
Calculated transaction value
$0
Sutherland Everett Rand Director
KRYS
Krystal Biotech
KRYS
Transaction date
Sep 14, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 3 days later
KRYS daily price context
Close on/before transaction
$340.03
Sep 14, 2026
Close before public filing
$336.67
Sep 16, 2026
Return since public filing
-0.0%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 1,187 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001852880-26-000002
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Krystal Biotech, Inc. KRYS Current | Award | Sep 14, 2026 | $0 |
| Krystal Biotech, Inc. KRYS | Award | Sep 14, 2026 | $0 |